abstract |
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 5-methanesulfonylpentanenitrile or 7-methanesulfonylheptanenitrile, or a pharmaceutically acceptable salt thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a 5-methanesulfonylpentanenitrile or 7-methanesulfonylheptanenitrile or a pharmaceutically acceptable salt thereof to a subject in need thereof. |